Delivery Order SPE2DB22D3011-SPE2DB24FQ2BT

Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,876.29 Delivery Order covers the supply of 4563282943 ! RIZATRIPTAN 5 MG ODT UD 3S, a prescription medication, with a period of performance ending on January 10, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,980.91, is for the delivery of RIZATRIPTAN 10 MG ODT UD 3S, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of May 10, 2023. The contract was not designated with a set-aside. AmerisourceBergen holds a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,122.94 Firm Fixed Price delivery order is for the provision of 4559321870 RIZATRIPTAN 10 MG ODT UD 18S, a specialty medication. The contract has a completion date of December 9, 2022. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $5,831.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RIZATRIPTAN 10 MG ODT UD 3S, a pharmaceutical product, with a completion date of May 5, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,867.38 firm fixed-price delivery order covers the supply of 4,563,750,623 units of Rizatriptan 10 mg tablets for an ultimate completion date of February 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $1,629.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of RIZATRIPTAN 5 MG ODT UD 18S, with a performance period ending on February 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,612.39 firm-fixed-price contract is for the delivery of 4,561,772,013 units of the prescription drug Rizatriptan 5 mg tablet. The contract has an ultimate completion date of August 11, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $1,346.16, is a delivery order for the pharmaceutical product RIZATRIPTAN 10 MG ODT UD 18S. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,466.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,535,486 units of RIZATRIPTAN 10 MG ODT UD 18S, a pharmaceutical product. The contract has a period of performance through February 5, 2024 and was awarded on February 2, 2024 on a firm fixed-price basis. This contract does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,468.43 delivery order contract is for the supply of RIZATRIPTAN 5 MG ODT UD 3S, a prescription medication. The award is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB24FQ2BT
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $7,238.14, is for the delivery of 4564945122 RIZATRIPTAN 10 MG ODT UD 3S. It is a firm fixed-price contract with a completion date of June 20, 2024.

Amerisourcebergen holds two larger indefinite delivery contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999.00 and $750,000 respectively, to provide a comprehensive range of pharmaceutical products and medical supplies to support various government agencies and military treatment programs. This specific contract award was made on an unrestricted basis without any set-aside designation.

Generated 9/17/24, 9:49 AM